Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1

Journal of Cellular Physiology

Volumn 215, Issue 1, 2008, Pages 68-76

  Majumdar, Manas K ^a,c   Chockalingam, Priya S ^a   Bhat, Ramesh A ^a   Sheldon, Richard ^a   Keohan, Cristin ^a,b   Blanchet, Tracey ^a   Glasson, Sonya ^a   Morris, Elisabeth A ^a  

^a PFIZER INC   (United States)

^b Regenerative Sciences Inc   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGGRECANASE; ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 2; COLLAGENASE 3; INTERLEUKIN 2; NITRIC OXIDE SYNTHASE; SCLEROPROTEIN; TRANSCRIPTION FACTOR SOX9; AUTACOID; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; INTERLEUKIN 1; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CATABOLISM; CELL CULTURE; CELL IMMORTALIZATION; CELL LINE; CELL STIMULATION; CYTOLOGY; EXTRACELLULAR MATRIX; FEMUR HEAD; FIBROBLAST; GENE EXPRESSION; MONOLAYER CULTURE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; DRUG EFFECT; ENZYMOLOGY; FEMUR; HUMAN; METABOLISM;

AGGRECANS; ALGINATES; ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CARTILAGE, ARTICULAR; CELL LINE, TRANSFORMED; CHONDROCYTES; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; FEMUR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MICE; PHENOTYPE; TRANSFORMING GROWTH FACTOR BETA;

EID: 39149123550     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21282     Document Type: Article

References (50)

1. Adolphe M, Froger B, Ronot X, Corvol MT, Forest N. 1984. Cell multiplication and type II collagen production by rabbit articular chondrocytes cultivated in a defined medium. Exp Cell Res 155:527-536.
2. Alema S, Tato F, Boettiger D. 1985. myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts. Mol Cell Biol 5:538-544.
3. Ali SH, DeCaprio JA. 2001. Cellular transformation by SV40 large T antigen: Interaction with host proteins. Semin Cancer Biol 11:15-23.
4. Arai M, Anderson D, Kurdi Y, Annis-Freeman B, Shields K, Collins-Racie LA, Corcoran C, DiBlasio-Smith E, Pittman DD, Dorner AJ, Morris E, LaVallie ER. 2004. Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system. Osteoarthritis Cartilage 12:599-613.
5. Arner EC. 2002. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2:322-329.
6. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. 2002. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46:2648-2657.
7. Benya PD, Shaffer JD. 1982. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30:215-224.
8. Bernier SM, Goltzman D. 1993. Regulation of expression of the chondrocyte phenotype in a skeletal cell line (CFK2) in vitro. J Bone Miner Res 8:475-484.
9. Castagnola P, Moro G, Descalzi-Cancedda F, Cancedda R. 1986. Type X collagen synthesis during in vitro development of chick embryo tibial chondrocytes. J Cell Biol 102:2310-2317.
10. Chen WH, Lai WF, Deng WP, Yang WK, Lo WC, Wu CC, Yang DM, Lai MT, Lin CT, Lin TW, Yang CB. 2006. Tissue engineered cartilage using human articular chondrocytes immortalized by HPV-16 E6 and E7 genes. J Biomed Mater Res A 76:512-520.
11. Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, Arai M, DiBlasio-Smith E, Dorner AJ, Georgiadis KE, Jin M, Tan XY, Morris EA, LaVallie ER. 2004. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 23:219-230.
12. Farndale RW, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173-177.
13. Finger F, Schorle C, Zien A, Gebhard P, Goldring MB, Aigner T. 2003. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/12. Arthritis Rheum 48:3395-3403.
14. Gebauer M, Saas J, Sohler F, Haag J, Soder S, Pieper M, Bartnik E, Beninga J, Zimmer R, Aigner T. 2005. Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthritis Cartilage 13:697-708.
15. Gionti E, Pontarelli G, Cancedda R. 1985. Avian myelocytomatosis virus immortalizes differentiated quail chondrocytes. Proc Natl Acad Sci USA 82:2756-2760.
16. Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, Flannery CR, Kanki K, Wang E, Peluso D, Yang Z, Majumdar MK, Morris EA. 2004. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 50:2547-2558.
17. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA. 2005. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644-648.
18. Goldring MB. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43:1916-1926.
19. Goldring MB, Krane SM. 1987. Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 262:16724-16729.
20. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, Arbiser JL, Apperley JF. 1994. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94:2307-2316.
21. Goldring MB, Tsuchimochi K, Ijiri K. 2006. The control of chondrogenesis. J Cell Biochem 97:33-44.
22. Grigolo B, Roseti L, Neri S, Gobbi P, Jensen P, Major EO, Facchini A. 2002. Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: Maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage 10:879-889.
23. Grigoriadis AE, Heersche JN, Aubin JE. 1988. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J Cell Biol 106:2139-2151.
24. Grunder T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK. 2004. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 12:559-567.
25. Hardingham TE, Fosang AJ. 1992. Proteoglycans: Many forms and many functions. FASEB J 6:861-870.
26. Horton WE Jr, Cleveland J, Rapp U, Nemuth G, Bolander M, Doege K, Yamada Y, Hassell JR. 1988. An established rat cell line expressing chondrocyte properties. Exp Cell Res 178:457-468.
27. Im HJ, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser RF. 2003. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 278:25386-25394.
28. Kaps C, Bramlage C, Smolian H, Haisch A, Ungethum U, Burmester GR, Sittinger M, Gross G, Haupl T. 2002. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 46:149-162.
29. Kokenyesi R, Tan L, Robbins JR, Goldring MB. 2000. Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys 383:79-90.
30. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
31. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
32. Majumdar MK, Banks V, Peluso DP, Morris EA. 2000. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 185:98-106.
33. Majumdar MK, Wang E, Morris EA. 2001. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189:275-284.
34. Majumdar MK, Chockalingam PS, Bhat RA, Sheldon R, Keohan C, Blanchet T, Glasson S, Morris EA. 2006. Immortalized cell lines from mouse xiphisternum preserve chondrocyte phenotype. J Cell Physiol 209:551-559.
35. Mallein-Gerin F, Olsen BR. 1993. Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype. Proc Natl Acad Sci USA 90:3289-3293.
36. Masuda K, Pfister BE, Sah RL, Thonar EJ. 2006. Osteogenic protein-1 promotes the formation of tissue-engineered cartilage using the alginate-recovered-chondrocyte method. Osteoarthritis Cartilage 14:384-391.
37. Mataga N, Tamura M, Yanai N, Shinomura T, Kimata K, Obinata M, Noda M. 1996, Establishment of a novel chondrocyte-like cell line derived from transgenic mice harboring the temperature-sensitive simian virus 40 large T-antigen gene. J Bone Miner Res 11:1646-1654.
38. Mok SS, Masuda K, Hauselmann HJ, Aydelotte MB, Thonar EJ. 1994. Aggrecan synthesized by mature bovine chondrocytes suspended in alginate. Identification of two distinct metabolic matrix pools. J Biol Chem 269:33021-33027.
39. Murakami S, Lefebvre V, de Crombrugghe B. 2000. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 275:3687-3692.
40. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. 2001. Composition and structure of articular cartilage: A template for tissue repair. Clin Orthop Relat Res 391:S26-S33.
41. Ronziere MC, Aubert-Foucher E, Gouttenoire J, Bernaud J, Herbage D, Mallein-Gerin F. 2005. Integrin alpha1beta1 mediates collagen induction of MMP-13 expression in MC615 chondrocytes. Biochim Biophys Acta 1746:55-64.
42. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM, Fosang AJ. 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648-652.
43. Steimberg N, Viengchareun S, Biehlmann F, Guenal I, Mignotte B, Adolphe M, Thenet S. 1999. SV40 large T antigen expression driven by col2a1 regulatory sequences immortalizes articular chondrocytes but does not allow stabilization of type II collagen expression. Exp Cell Res 249:248-259.
44. Takazawa Y, Nifuji A, Mataga N, Yamauchi Y, Kurosawa H, Noda M. 1999. Articular cartilage cells immortalized by a temperature sensitive mutant of SV40 large T antigen survive and form cartilage tissue in articular cartilage environment. J Cell Biochem 75:338-345.
45. Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita A, Suzuki F, Takano Y, Mori Y. 1989. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49:3996-4002.
46. Thenet S, Benya PD, Demignot S, Feunteun J, Adolphe M. 1992. SV40-immortalization of rabbit articular chondrocytes: Alteration of differentiated functions. J Cell Physiol 150:158-167.
47. Valcourt U, Ronziere MC, Winkler P, Rosen V, Herbage D, Mallein-Gerin F. 1999. Different effects of bone morphogenetic proteins 2, 4, 12,and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res 251:264-274.
48. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. 1998. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-1757.
49. Yoon BS, Pogue R, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM. 2006. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 133:4667-4678.
50. Zeng W, Corcoran C, Collins-Racie LA, Lavallie ER, Morris EA, Flannery CR. 2006. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: Comparative analyses with ADAMTS-5, -9, -16 and -18. Biochim Biophys Acta 1760:517-524.